Contact
Please use this form to send email to PR contact of this press release:
Sirnaomics Receives FDA Clearance to Initiate Phase 2 Study of STP705 for the Treatment of Non-Melanoma Skin Cancer
TO:
George Ji
Sirnaomics Inc.
+1 3017401730